ISOLATION OF CALIFORNIA ENCEPHALITIS GROUP VIRUS FROM A FATAL HUMAN ILLNESS.
about
Microculture plaque neutralization test for California group arbovirusesCharacterization of La Crosse virus RNA in autopsied central nervous system tissuesHuman MxA protein protects mice lacking a functional alpha/beta interferon system against La crosse virus and other lethal viral infectionsMutagenesis of the La Crosse Virus glycoprotein supports a role for Gc (1066–1087) as the fusion peptideGenome sequence analysis of La Crosse virus and in vitro and in vivo phenotypesInhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA proteinAnalysis of La Crosse virus S-segment RNA and its positive-sense transcripts in persistently infected mosquito tissuesAnalysis of LaCrosse virus S mRNA 5' termini in infected mosquito cells and Aedes triseriatus mosquitoesLa Crosse virus infectivity, pathogenesis, and immunogenicity in mice and monkeysReverse transcription-PCR detection of LaCrosse virus in mosquitoes and comparison with enzyme immunoassay and virus isolationProduction and use of a hemagglutinin for detecting antibody to Jamestown Canyon virusThe Incidence Risk, Clustering, and Clinical Presentation of La Crosse Virus Infections in the Eastern United States, 2003–2007Serum dilution neutralization test for California group virus identification and serologyLa Crosse virus soluble cell culture antigenDiagnosis of California La Crosse virus infection by counterimmunoelectrophoresisElectron microscopy of vitrified-hydrated La Crosse virusNucleocapsid protein structures from orthobunyaviruses reveal insight into ribonucleoprotein architecture and RNA polymerizationArbovirus InfectionsLa Crosse and other forms of California encephalitis.The spatial epidemiology and clinical features of reported cases of La Crosse virus infection in West Virginia from 2003 to 2007.North American encephalitic arbovirusesAntivirally active MxA protein sequesters La Crosse virus nucleocapsid protein into perinuclear complexes.The demographic and socioeconomic factors predictive for populations at high-risk for La Crosse virus infection in West Virginia.A recombinant chimeric La Crosse virus expressing the surface glycoproteins of Jamestown Canyon virus is immunogenic and protective against challenge with either parental virus in mice or monkeys.Medically important arboviruses of the United States and CanadaMechanism of La Crosse virus inhibition by ribavirin.Role of nucleotide binding and GTPase domain dimerization in dynamin-like myxovirus resistance protein A for GTPase activation and antiviral activity.Arboviral encephalitides: transmission, emergence, and pathogenesis.Prion Strain Differences in Accumulation of PrPSc on Neurons and Glia Are Associated with Similar Expression Profiles of Neuroinflammatory Genes: Comparison of Three Prion StrainsLa Crosse Virus Field Detection and Vector Competence of Culex Mosquitoes.Recombination between snowhoe hare and La Crosse bunyavirusesStructural proteins of La Crosse virus.Activation of RNase L is dependent on OAS3 expression during infection with diverse human virusesCell-type-specific activation of the oligoadenylate synthetase-RNase L pathway by a murine coronavirus.Development of four arboviruses in mice and application to rapid test procedures.Preparation of La Crosse virus hemagglutinating antigen in BHK-21 suspension cell cultures.Lymphocytes have a role in protection, but not in pathogenesis, during La Crosse Virus infection in mice.La Crosse virus (LACV) Gc fusion peptide mutants have impaired growth and fusion phenotypes, but remain neurotoxic.Impact of transmission cycles and vector competence on global expansion and emergence of arboviruses.Periodic lateralized epileptiform discharges in La Crosse encephalitis, a worrisome subgroup: clinical presentation, electroencephalogram (EEG) patterns, and long-term neurologic outcome.
P2860
Q24685262-57AABDD9-C82E-40D8-B210-10D647A7CE2EQ27469423-E0C60845-0E77-43E2-B145-BE0279D6A454Q27469723-4FAFB4C9-FDDF-427E-8FA3-523C6475A394Q27478164-C66CDBA5-DE9A-4D4C-B495-28FEC09FAB3DQ27478428-00F3D641-1D21-4522-B286-1BAB14E90311Q27480330-D97100F9-C631-4EDA-8694-469C4ECF14E3Q27480764-81B1C3F0-61F0-4687-9569-55C7D4DEC2B5Q27480828-1C763988-5EB8-4221-B2D8-F109791B85F6Q27485632-F3270377-240C-4359-B7B4-155293FF8DDAQ27487884-1D992931-11E1-4CBA-895F-DFF11111671FQ27488693-F55F22B3-BDD4-4A0C-81D1-3EFD699DEF49Q27488850-BF4E10AE-35BA-420E-9C00-0732FC5F4B8DQ27489624-3184D26F-948D-4851-AF68-5C43E81DF2FAQ27489706-396BDFAC-D4D6-4B3D-8443-236CAB049ED9Q27489739-AC9244D1-B65B-45E9-BF89-840DEAEA55F6Q27491043-10DA6AA7-6E16-422E-B75E-B3B41D2BED92Q27677429-62B144CE-179D-4A0A-BD41-F017F958E058Q28081847-E40120C9-A7C7-4700-9CCB-5B331716A14AQ33534656-5A755403-9267-4038-BF10-6D46ABDE51A1Q33804484-32B58553-958D-405A-B5FF-2EB69944EABBQ33835377-F4CC60C9-985C-4698-896C-4B918CF22638Q34016778-B133CC60-3BFA-4762-BC73-793BF799007AQ34043494-C9E29787-C772-4D50-81C9-A9BAF78A4B1BQ34225723-194390AF-5D3C-4E2C-88BC-0DED3068E72DQ34336519-87AAC25B-D664-4506-B25E-75B2959A49ADQ35361328-A04D1660-65D4-4A2E-B30E-F3A5C77AD7ADQ35608130-C1FE45D9-573A-49A5-BF2E-1F3D475AE889Q35778817-73ABC54D-A391-4560-824A-7C24B825C87CQ35979953-554A0253-BCBE-43AC-BA6F-DDF4B9A405EEQ36026217-76668832-7841-4EA4-8A34-736D32AE2304Q36501990-752B82A3-F468-4C3B-8AE6-8FF24A211E35Q36546537-DA3B179D-D0FC-4C9C-827E-05DAC330B783Q36646342-5FA11EB2-19C7-4003-AD42-44269E55B903Q37036782-7A538A70-86F4-47F3-874E-68C20EEE0A73Q37161277-165DCE05-019E-4DA4-9581-47D1EC84D431Q37190139-98368B0D-2088-4FCC-97DA-FDBB5F81C241Q37719663-1401E8B6-6C6A-4EB7-8964-F0D164E837ECQ39692178-EF56602C-6959-4E07-B3E5-5A33F9725671Q40063521-F086C117-1F1F-4CCC-9237-0FE795076BEAQ40431057-B86B6819-B0E5-42BE-8110-52D2D96B4D4D
P2860
ISOLATION OF CALIFORNIA ENCEPHALITIS GROUP VIRUS FROM A FATAL HUMAN ILLNESS.
description
1965 nî lūn-bûn
@nan
1965 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1965 թվականի մարտին հրատարակված գիտական հոդված
@hy
1965年の論文
@ja
1965年論文
@yue
1965年論文
@zh-hant
1965年論文
@zh-hk
1965年論文
@zh-mo
1965年論文
@zh-tw
1965年论文
@wuu
name
ISOLATION OF CALIFORNIA ENCEPHALITIS GROUP VIRUS FROM A FATAL HUMAN ILLNESS.
@ast
ISOLATION OF CALIFORNIA ENCEPHALITIS GROUP VIRUS FROM A FATAL HUMAN ILLNESS.
@en
ISOLATION OF CALIFORNIA ENCEPHALITIS GROUP VIRUS FROM A FATAL HUMAN ILLNESS.
@nl
type
label
ISOLATION OF CALIFORNIA ENCEPHALITIS GROUP VIRUS FROM A FATAL HUMAN ILLNESS.
@ast
ISOLATION OF CALIFORNIA ENCEPHALITIS GROUP VIRUS FROM A FATAL HUMAN ILLNESS.
@en
ISOLATION OF CALIFORNIA ENCEPHALITIS GROUP VIRUS FROM A FATAL HUMAN ILLNESS.
@nl
prefLabel
ISOLATION OF CALIFORNIA ENCEPHALITIS GROUP VIRUS FROM A FATAL HUMAN ILLNESS.
@ast
ISOLATION OF CALIFORNIA ENCEPHALITIS GROUP VIRUS FROM A FATAL HUMAN ILLNESS.
@en
ISOLATION OF CALIFORNIA ENCEPHALITIS GROUP VIRUS FROM A FATAL HUMAN ILLNESS.
@nl
P2093
P1476
ISOLATION OF CALIFORNIA ENCEPHALITIS GROUP VIRUS FROM A FATAL HUMAN ILLNESS.
@en
P2093
KALFAYAN B
THOMPSON WH
P304
P356
10.1093/OXFORDJOURNALS.AJE.A120512
P407
P577
1965-03-01T00:00:00Z